Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclophilins are a family of conserved enzymes possessing peptidyl-prolyl cis-trans isomerase activity, accelerating the interconversion of cis and trans forms of peptide bonds before proline residues[3][7]. This function is critical for proper protein folding, prevention of aggregation, and assembly of multidomain proteins. Cyclophilins are found throughout cellular compartments—cytosol, nucleus, mitochondria, and even secreted forms. They became widely studied after the discovery of their high-affinity binding to cyclosporin A, an immunosuppressive drug, and mediate CsA’s action by forming a ternary complex with calcineurin—this blocks T-cell activation and is the basis for CsA’s clinical use in transplantation and autoimmune diseases[3][5]. Beyond immunology, particular isoforms such as Cyclophilin D are central to cell death pathways via regulation of mitochondrial permeability transition pores[6]. Cyclophilins are also implicated in viral replication (HIV, HCV), cancer, neurodegeneration, cardiovascular disease, and inflammation, making them an attractive and versatile therapeutic target whose inhibition remains a key area of drug development[3][5][7]. Key structural features include a highly conserved β-barrel fold and PPIase active site, with specificity determined by side pockets in the structure and additional domains in multidomain isoforms[1][2][4].
Inhibition of peptidyl-prolyl isomerase activity (by CsA and other inhibitors) Disruption of Cyclophilin-dependent protein folding and assembly Immunosuppression via inhibition of calcineurin with CsA-Cyclophilin complex
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclophilin (peptidyl-prolyl cis-trans isomerase family) (CYP (commonly CypA, CypB, CypC, CypD for isoforms)).